Remedi, HLGeNomics Debut on South Korea's KOSDAQ This Week at 20,700 and 21,500 Won

According to Yonhapinfomax, Remedi, a manufacturer of portable medical X-ray imaging devices, is set to list on South Korea's KOSDAQ market on July 13 at a public offering price of 20,700 won, following a 1,146-to-1 subscription competition rate. HLGeNomics, an active pharmaceutical ingredients (API) specialist with 19 consecutive years of profitability, will also debut this week at 21,500 won, with 98.5% of participating institutions supporting the upper-band pricing.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments